Literature DB >> 31860811

Unilateral pallidotomy in the treatment of cervical dystonia: a retrospective observational study.

Shiro Horisawa, Atsushi Fukui, Kotaro Kohara, Takakazu Kawamata, Takaomi Taira.   

Abstract

OBJECTIVE: The objective of this study was to assess the efficacy of unilateral pallidotomy in patients with asymmetrical cervical dystonia.
METHODS: This study retrospectively included 25 consecutive patients with asymmetrical cervical dystonia refractory to botulinum toxin injections, who underwent unilateral pallidotomy between January 2015 and April 2017. Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores were evaluated preoperatively and 1 week, 3 months, and 6 months postoperatively. The clinical responses were defined as good responders, exhibiting > 50% improvement in the TWSTRS score at 6 months postsurgery, or poor responders, exhibiting < 50% improvement in TWSTRS scores at 6 months postsurgery.
RESULTS: Twelve and 9 patients showed right- and left-side rotation, respectively; 1 and 3 patients had right- and left-side laterocollis, respectively. The mean age of onset and duration of the disease were 40.2 ± 13.9 and 8.9 ± 10.9 years, respectively. Mean TWSTRS scores were 38.4 ± 12.6 (p < 0.001), 17.3 ± 12.4 (p < 0.001), 19.5 ± 13.4 (p < 0.001), and 20.0 ± 14.7 (p < 0.001), preoperatively and 1 week, 3 months, and 6 months postoperatively, respectively. Fourteen patients (56%) demonstrated > 50% improvement in their TWSTRS total score (mean improvement of TWSTRS total score = 70.5%) 6 months postsurgically. Furthermore, preoperative TWSTRS severity score was a prognostic factor (odds ratio 1.37, 95% confidence interval 1.06-1.78, p = 0.003).
CONCLUSIONS: These results suggest that unilateral pallidotomy is an acceptable treatment option for asymmetrical cervical dystonia. Further investigations with a larger number of cases and longer follow-up period are required to confirm these data.

Entities:  

Keywords:  BFMDRS = Burke-Fahn-Marsden Dystonia Rating Scale; DBS = deep brain stimulation; GPi = globus pallidus internus; SCM = sternocleidomastoid muscle; TWSTRS = Toronto Western Spasmodic Torticollis Rating Scale; VL = ventrolateral; VOi = ventro-oral intermediate; cervical dystonia; functional neurosurgery; globus pallidus internus; pallidotomy

Year:  2019        PMID: 31860811     DOI: 10.3171/2019.9.JNS191202

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Successful Treatment of Auricular Dystonia by Unilateral Pallidothalamic Tractotomy.

Authors:  Kilsoo Kim; Shiro Horisawa; Kotaro Kohara; Taku Nonaka; Takakazu Kawamata; Takaomi Taira
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-01-22

2.  Modified McKenzie-Dandy operation for a cervical dystonia patient who failed selective peripheral denervation: A case report and literature review.

Authors:  Chumpon Jetjumnong; Thunya Norasetthada
Journal:  Surg Neurol Int       Date:  2022-01-29

3.  Unilateral pallidothalamic tractotomy at Forel's field H1 for cervical dystonia.

Authors:  Shiro Horisawa; Kotaro Kohara; Taku Nonaka; Atsushi Fukui; Tatsuki Mochizuki; Mutsumi Iijima; Takakazu Kawamata; Takaomi Taira
Journal:  Ann Clin Transl Neurol       Date:  2022-03-08       Impact factor: 4.511

4.  Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study.

Authors:  Shiro Horisawa; Kotaro Kohara; Hiroki Ebise; Masahiko Nishitani; Takakazu Kawamata; Takaomi Taira
Journal:  Front Neurol       Date:  2022-05-03       Impact factor: 4.003

Review 5.  Parameters for subthalamic deep brain stimulation in patients with dystonia: a systematic review.

Authors:  Yuhan Wang; Chencheng Zhang; Bomin Sun; Dianyou Li; Yiwen Wu
Journal:  J Neurol       Date:  2021-01-01       Impact factor: 4.849

6.  Safety and efficacy of unilateral and bilateral pallidotomy for primary dystonia.

Authors:  Shiro Horisawa; Atsushi Fukui; Nobuhiko Takeda; Takakazu Kawamata; Takaomi Taira
Journal:  Ann Clin Transl Neurol       Date:  2021-03-15       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.